Cameron Turtle, Chief Business Officer

EIDX 52,121 shares
BBIO 12,568 shares

The estimated Net Worth of Cameron Turtle is at least $4,449,473.00. Cameron Turtle owns over 52,121 units of Eidos Therapeutics, Inc. stock worth over $3,920,989.86.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
11th November 2020EIDX - Eidos Therapeutics, Inc.1,500Bona fide gift50,621$0.00
11th November 2020EIDX - Eidos Therapeutics, Inc.908Open or private sale52,121$75.23$68,307.57$3,920,989.86
11th November 2020EIDX - Eidos Therapeutics, Inc.9,497Open or private sale53,029$74.75$709,859.91$3,963,689.73
11th November 2020EIDX - Eidos Therapeutics, Inc.3,005Open or private sale62,526$73.56$221,059.82$4,599,662.66
5th November 2020BBIO - BridgeBio Pharma, Inc.2,500Open or private sale12,568$42.05$105,124.75$528,483.14
5th November 2020BBIO - BridgeBio Pharma, Inc.2,500Exercise of derivative15,068$17.00$42,500.00$256,156.00
2nd November 2020EIDX - Eidos Therapeutics, Inc.209Open or private sale65,531$72.10$15,068.08$4,724,529.53
2nd November 2020EIDX - Eidos Therapeutics, Inc.3,146Open or private sale65,740$71.42$224,676.94$4,694,933.86
2nd November 2020EIDX - Eidos Therapeutics, Inc.9,145Open or private sale68,886$70.44$644,208.55$4,852,591.61
2nd November 2020EIDX - Eidos Therapeutics, Inc.2,500Exercise of derivative78,031$17.00$42,500.00$1,326,527.00
2nd November 2020EIDX - Eidos Therapeutics, Inc.5,000Exercise of derivative75,531$13.20$66,000.00$997,009.20
30th September 2020BBIO - BridgeBio Pharma, Inc.2,058Open or private sale12,568$38.24$78,706.98$480,655.62
30th September 2020BBIO - BridgeBio Pharma, Inc.12,442Open or private sale14,626$37.59$467,750.77$549,857.16
30th September 2020BBIO - BridgeBio Pharma, Inc.6,000Exercise of derivative27,068$0.34$2,040.00$9,203.12
30th September 2020BBIO - BridgeBio Pharma, Inc.6,000Exercise of derivative21,068$0.16$960.00$3,370.88
30th September 2020BBIO - BridgeBio Pharma, Inc.2,500Exercise of derivative15,068$17.00$42,500.00$256,156.00
18th September 2020BBIO - BridgeBio Pharma, Inc.2,500Open or private sale12,568$42.01$105,024.25$527,977.91
18th September 2020BBIO - BridgeBio Pharma, Inc.2,500Exercise of derivative15,068$17.00$42,500.00$256,156.00
15th September 2020BBIO - BridgeBio Pharma, Inc.2,500Open or private sale12,568$37.06$92,651.75$465,778.88
15th September 2020BBIO - BridgeBio Pharma, Inc.2,500Exercise of derivative15,068$17.00$42,500.00$256,156.00
4th June 2019EIDX - Eidos Therapeutics, Inc.3,300Open or private sale100,155$32.27$106,491.00$3,232,001.85
4th June 2019EIDX - Eidos Therapeutics, Inc.6,700Open or private sale103,455$31.33$209,911.00$3,241,245.15
31st May 2019EIDX - Eidos Therapeutics, Inc.1,769Grant/award etc.110,155$12.01$21,245.69$1,322,961.55
30th November 2018EIDX - Eidos Therapeutics, Inc.1,081Grant/award etc.108,386$12.01$12,982.81$1,301,715.86
1st July 2019BBIO - BridgeBio Pharma, Inc.9,262Exercise of derivative12,630$0.00
1st July 2019BBIO - BridgeBio Pharma, Inc.3,368Exercise of derivative3,368$0.00
4th September 2019EIDX - Eidos Therapeutics, Inc.643Open or private sale95,155$42.09$27,063.87$4,005,073.95
4th September 2019EIDX - Eidos Therapeutics, Inc.4,357Open or private sale95,798$41.51$180,859.07$3,976,574.98
11th September 2020BBIO - BridgeBio Pharma, Inc.2,000Open or private sale12,568$35.02$70,047.00$440,175.35
11th September 2020BBIO - BridgeBio Pharma, Inc.2,000Exercise of derivative14,568$0.34$680.00$4,953.12
20th November 2019EIDX - Eidos Therapeutics, Inc.2,532Open or private sale85,155$56.36$142,696.94$4,799,114.40
20th November 2019EIDX - Eidos Therapeutics, Inc.7,468Open or private sale87,687$55.54$414,804.83$4,870,513.03
6th December 2019EIDX - Eidos Therapeutics, Inc.8,900Open or private sale85,155$59.43$528,921.66$5,060,710.56
6th December 2019EIDX - Eidos Therapeutics, Inc.700Open or private sale94,055$58.28$40,793.97$5,481,252.64
6th December 2019EIDX - Eidos Therapeutics, Inc.400Open or private sale94,755$56.84$22,736.00$5,385,874.20
6th December 2019EIDX - Eidos Therapeutics, Inc.10,000Exercise of derivative95,155$13.20$132,000.00$1,256,046.00
8th January 2020BBIO - BridgeBio Pharma, Inc.4,802Open or private sale9,823$34.71$166,669.74$340,940.61
8th January 2020BBIO - BridgeBio Pharma, Inc.8,005Open or private sale14,625$34.17$273,541.26$499,755.26
8th January 2020BBIO - BridgeBio Pharma, Inc.10,000Exercise of derivative22,630$17.00$170,000.00$384,710.00
3rd February 2020EIDX - Eidos Therapeutics, Inc.7,211Open or private sale80,155$53.89$388,636.12$4,319,945.71
3rd February 2020EIDX - Eidos Therapeutics, Inc.5,289Open or private sale87,366$53.32$282,003.66$4,658,259.02
3rd February 2020EIDX - Eidos Therapeutics, Inc.2,500Exercise of derivative92,655$17.00$42,500.00$1,575,135.00
3rd February 2020EIDX - Eidos Therapeutics, Inc.5,000Exercise of derivative90,155$13.20$66,000.00$1,190,046.00
11th February 2020BBIO - BridgeBio Pharma, Inc.2,000Open or private sale9,823$37.28$74,564.20$366,222.07
11th February 2020BBIO - BridgeBio Pharma, Inc.2,000Exercise of derivative11,823$17.00$34,000.00$200,991.00
8th April 2020BBIO - BridgeBio Pharma, Inc.8,000Open or private sale9,823$27.04$216,357.60$265,660.09
8th April 2020BBIO - BridgeBio Pharma, Inc.8,000Exercise of derivative17,823$17.00$136,000.00$302,991.00
27th April 2020BBIO - BridgeBio Pharma, Inc.2,000Open or private sale9,823$32.01$64,027.60$314,471.56
27th April 2020BBIO - BridgeBio Pharma, Inc.2,000Exercise of derivative11,823$17.00$34,000.00$200,991.00
1st May 2020EIDX - Eidos Therapeutics, Inc.20Open or private sale75,155$43.26$865.20$3,251,205.30
1st May 2020EIDX - Eidos Therapeutics, Inc.1,180Open or private sale75,175$42.56$50,220.45$3,199,425.45
1st May 2020EIDX - Eidos Therapeutics, Inc.1,050Open or private sale76,355$41.23$43,286.56$3,147,757.78
1st May 2020EIDX - Eidos Therapeutics, Inc.7,750Open or private sale77,405$40.52$314,061.00$3,136,760.22
1st May 2020EIDX - Eidos Therapeutics, Inc.5,000Exercise of derivative85,155$13.20$66,000.00$1,124,046.00
26th May 2020EIDX - Eidos Therapeutics, Inc.2,500Open or private sale75,155$47.00$117,500.00$3,532,285.00
26th May 2020EIDX - Eidos Therapeutics, Inc.2,500Exercise of derivative77,655$17.00$42,500.00$1,320,135.00
31st May 2020EIDX - Eidos Therapeutics, Inc.376Grant/award etc.75,531$41.57$15,631.64$3,140,088.03
30th June 2020BBIO - BridgeBio Pharma, Inc.300Open or private sale9,823$33.17$9,951.99$325,861.33
30th June 2020BBIO - BridgeBio Pharma, Inc.9,700Open or private sale10,123$32.65$316,671.05$330,480.52
30th June 2020BBIO - BridgeBio Pharma, Inc.4,000Exercise of derivative19,823$0.34$1,360.00$6,739.82
30th June 2020BBIO - BridgeBio Pharma, Inc.6,000Exercise of derivative15,823$0.16$960.00$2,531.68
3rd August 2020EIDX - Eidos Therapeutics, Inc.500Open or private sale70,531$40.89$20,446.35$2,884,203.02
3rd August 2020EIDX - Eidos Therapeutics, Inc.6,700Open or private sale71,031$40.25$269,671.65$2,858,962.23
3rd August 2020EIDX - Eidos Therapeutics, Inc.2,800Open or private sale77,731$39.05$109,331.88$3,035,170.13
3rd August 2020EIDX - Eidos Therapeutics, Inc.5,000Exercise of derivative80,531$13.20$66,000.00$1,063,009.20
1st September 2020BBIO - BridgeBio Pharma, Inc.2,745Grant/award etc.12,568$0.00
10th September 2020EIDX - Eidos Therapeutics, Inc.2,500Open or private sale70,531$47.00$117,500.00$3,314,957.00
10th September 2020EIDX - Eidos Therapeutics, Inc.2,500Exercise of derivative73,031$17.00$42,500.00$1,241,527.00